NORWALK, Conn. -- Grammy Award-winning singers Smokey Robinson and CeeLo Green along with NBC’s "America’s Got Talent" host Nick Cannon will join the Norwalk-based Multiple Myeloma Research Foundation at its Annual Fall Gala on Saturday, Oct. 29 in Old Greenwich.
Philanthropists and Greenwich residents Anne and David Ogilvy will be presented with the foundation's Spirit of Hope Award.
The award is given annually to patients, caregivers, family members or advocates who inspire hope through their resilience, perseverance and dedication to the foundation and its mission, said a release.
"As a patient, I am immensely grateful to the (foundation) for shifting the paradigm of cancer research and for revolutionizing the way myeloma is treated. Caregivers are the true spirit of hope and I am inspired by my caregiver, my amazing wife, Anne, for her unflappable bravery and strength, as well as my entire family. Without my doctors and the MMRF, I would not be here today,” said David Ogilvy, the president and owner of David Ogilvy & Associates Realtors.
Songwriter and record producer Robinson will be presented with the foundation's Courage and Commitment Award.
Robinson is a Rock ‘n’ Roll Hall of Fame inductee and has received numerous awards including the Grammy Living Legend Award, NARAS Lifetime Achievement Award, Howard University Honorary Doctorate, Kennedy Center Honors and the National Medal of Arts Award from the President of the United States.
Both of these awards are presented to people in recognition of their extraordinary contributions and inspiration of hope through their life’s work.
Singer, songwriter and record producer Green will serve as the evening’s headliner.
The evening’s Master of Ceremonies will be TV host Nick Cannon, an entrepreneur, philanthropist and entertainer.
Janssen Oncology and Takeda Oncology are the evening's presenting sponsors.
“The awareness that we generate and the funds that we raise supports the MMRF’s unique Precision Medicine Model, the promise of delivering tailored cancer treatments based on a patient’s specific genetic profile. This is the future of cancer research," said President and Chief Executive Officer Paul Giusti, Multiple Myeloma Research Foundation.
The cancer research organization's mission is to pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure.